North America Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Therapy Type (Allogeneic and Autologous), Product (Consumables, Equipment, and Systems and Software), Technology (Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, and Three-Dimensional Technology), Application (Oncology, Cardiovascular, Orthopedic, Wound Management, and Other Applications), and End User (Research Institutes, Hospitals, and Others), and Country
Market Introduction
Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy also has applications in the development of regenerative medicines.
Get more information on this report :
Market Overview and Dynamics
The North America cell therapy market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019. The market is anticipated to grow at a CAGR of 7.4% from 2020 to 2027. Factors driving the market growth include growing collaborative efforts to promote cell therapy, and developments in cell therapy against COVID–19. However, stringent regulations is likely to restraint the market growth during the forecast period.
Key Market Segments
In terms of therapy type, in 2019, the allogeneic, and autologous. The allogeneic segment held the largest share of the market in 2019. The growth of segment is expected due to increasing focus on the development of regenerative therapies by increasingly emphasizing innovations and manufacturing. In addition, the availability of substantial number of approved products for clinical use is likely to continue the growth of segment during the forecast period. However, the autologous segment is anticipated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
World Health Organization, Food and Drug Administration, and American Society of Gene & Cell Therapy, and Stem Cell Network are some of the major primary and secondary sources for the North America cell therapy market included in the report.
Reasons to buy the report
- To understand the North America cell therapy market landscape and identify market segments that are most likely to guarantee a strong return
- To stay ahead of the race by comprehending the ever-changing competitive landscape for the North America cell therapy market
- To efficiently plan M&A and partnership deals in the North America cell therapy market by identifying market segments with the most promising probable sales
- To help in taking knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments of the North America cell therapy market
- To obtain market revenue forecast for market by various segments from 2019 to 2027 in the region
North America Cell Therapy Market Segmentation
By Therapy Type
- Allogeneic
- Autologous
By Product
- Consumables
- Equipment
- Systems and Software
By Technology
- Viral Vector Technology
- Genome Editing Technology
- Somatic Cell Technology
- Cell Immortalization Technology
- Cell Plasticity Technology
- Three-Dimensional Technology
By Application
- Oncology
- Cardiovascular
- Orthopedic
- Wound Management
- Other Applications
By End User
- Research Institutes
- Hospitals
- Others
Company Profiles
- Vericel Corporation
- MEDIPOST
- NuVasive, Inc
- Mesoblast Limited
- Smith & Nephew
- Bristol-Myers Squibb Company
- Stemedica Cell Technologies, Inc
- Castle Creek Biosciences, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North American Cell Therapy Market– By Therapy Type
1.3.2 North American Cell Therapy Market– By Product
1.3.3 North American Cell Therapy Market – By Technology
1.3.4 North American Cell Therapy Market – By Application
1.3.5 North American Cell Therapy Market – By End User
1.3.6 North American Cell Therapy Market– By Region
2. Cell Therapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Cell Therapy – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Expert Opinion
5. North America Cell Therapy Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Growing Collaborative Efforts to Promote Cell Therapy
5.1.2 Developments in Cell Therapy Against COVID–19
5.2 Key Market Restraints
5.2.1 Stringent Regulations
5.3 Key Market Opportunities
5.3.1 Focus on Cell Therapy to Treat Diabetes
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact Analysis
6. Cell Therapy Market – Regional Analysis
6.1 North America Cell Therapy Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players
7. Cell Therapy Market Analysis – By Therapy Type
7.1 Overview
7.2 Cell Therapy Market Revenue Share, by Therapy Type, 2019 and 2027 (%)
7.2.1 North America Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
7.3 Allogeneic
7.3.1 Overview
7.3.2 Allogeneic: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Autologous
7.4.1 Overview
7.4.2 Autologous: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
8. Cell Therapy Market – By Product
8.1 Overview
8.2 Cell Therapy Market, by Product, 2019 and 2027 (%)
8.2.1 North America Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
8.3 Consumables
8.3.1 Overview
8.3.2 Consumables: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Equipment
8.4.1 Overview
8.4.2 Equipment: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Systems and Software
8.5.1 Overview
8.5.2 Systems and Software: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9. Cell Therapy Market – By Technology
9.1 Overview
9.2 Cell Therapy Market, by Technology, 2019 and 2027 (%)
9.2.1 North America Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
9.3 Viral Vector Technology
9.3.1 Overview
9.3.2 Viral Vector Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Genome Editing Technology
9.4.1 Overview
9.4.2 Genome Editing Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Somatic Cell Technology
9.5.1 Overview
9.5.2 Somatic Cell Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Cell Immortalization Technology
9.6.1 Overview
9.6.2 Cell Immortalization Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Cell Plasticity Technology
9.7.1 Overview
9.7.2 Cell Plasticity Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.8 Three-Dimensional Technology
9.8.1 Overview
9.8.2 Three-Dimensional Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
10. Cell Therapy Market – By Application
10.1 Overview
10.2 Cell Therapy Market, by Application, 2019 and 2027 (%)
10.2.1 North America Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular
10.4.1 Overview
10.4.2 Cardiovascular: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.5 Orthopedic
10.5.1 Overview
10.5.2 Orthopedic: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.6 Wound Management
10.6.1 Overview
10.6.2 Wound Management: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.7 Other Applications
10.7.1 Overview
10.7.2 Other Applications: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
11. Cell Therapy Market – By End User
11.1 Overview
11.2 Cell Therapy Market, by End User, 2019 and 2027 (%)
11.2.1 North America Cell Therapy Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
11.4 Research Institutes
11.4.1 Overview
11.4.2 Research Institutes: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
12. Cell Therapy Market– Regional Analysis
12.1 North America: Cell Therapy Market
12.1.1 Overview
12.1.2 North America: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.3 North America: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.4 North America: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.5 North America: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.6 North America: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.7 North America: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
12.1.8 North America: Cell Therapy Market, by Country, 2019 & 2027 (%)
12.1.9 US: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.1 US: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.2 US: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.9.3 US: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.9.4 US: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.9.5 US: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.9.6 US: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
12.1.10 Canada: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.1 Canada: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.2 Canada: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.10.3 Canada: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.10.4 Canada: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.10.5 Canada: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.10.6 Canada: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
12.1.11 Mexico: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.11.1 Mexico: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.11.2 Mexico: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.11.3 Mexico: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.11.4 Mexico: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.11.5 Mexico: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.11.6 Mexico: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
13. Impact of COVID-19 Pandemic on North America Cell Therapy Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
14. Cell therapy Market–Key Company Profiles
14.1 Vericel Corporation
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 MEDIPOST
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 NuVasive, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Mesoblast Limited
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Smith & Nephew
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Stemedica Cell Technologies, Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Castle Creek Biosciences, Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Cell Therapy Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. North America: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 7. North America: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. North America: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 9. North America: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. North America: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 11. US: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. US: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 13. US: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 14. US: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. US: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Canada: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Canada: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. Canada: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 19. Canada: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. Canada: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 21. Mexico: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 22. Mexico: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 23. Mexico: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 24. Mexico: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. Mexico: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 26. Glossary of Terms, Cell Therapy Market
LIST OF FIGURES
Figure 1. Cell Therapy Market Segmentation
Figure 2. Cell Therapy Market Segmentation – By Region
Figure 3. North America Cell Therapy Market Overview
Figure 4. Allogeneic Segment Held Largest Share Of Therapy Type Segment In The Cell Therapy Market
Figure 5. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Cell Therapy Market – Revenue Forecast And Analysis – 2019- 2027
Figure 8. Market Positioning Of Key Players In Cell Therapy Market
Figure 9. Cell Therapy Market Revenue Share, by Therapy Type, 2019 and 2027 (%)
Figure 10. Allogeneic: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Autologous: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Cell Therapy Market, by Product 2019 and 2027 (%)
Figure 13. Consumables: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Equipment: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Systems and Software: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Cell Therapy Market, by Technology, 2019 and 2027 (%)
Figure 17. Viral Vector Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Genome Editing Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Somatic Cell Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cell Immortalization Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cell Plasticity Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Three-Dimensional Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Cell Therapy Market, by Application, 2019 and 2027 (%)
Figure 24. Oncology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Cardiovascular: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Orthopedic: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Wound Management: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Other Applications: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Cell Therapy Market, by End User, 2019 and 2027 (%)
Figure 30. Hospitals Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Research Institutes: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Others: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Cell Therapy Market, by Key Country – Revenue (2019) (USD Million)
Figure 34. North America: Cell Therapy Market Revenue and Forecast to 2027 (USD Million)
Figure 35. North America: Cell Therapy Market, by Country, 2019 & 2027 (%)
Figure 36. US: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Canada: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Mexico: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in North American Country Markets
- Vericel Corporation
- MEDIPOST
- NuVasive, Inc
- Mesoblast Limited
- Smith & Nephew
- Bristol-Myers Squibb Company
- Stemedica Cell Technologies, Inc
- Castle Creek Biosciences, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America cell therapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America cell therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.